Related references
Note: Only part of the references are listed.Unexpected Abnormal Uptake in the Breasts at Dedicated Breast PET: Incidentally Detected Small Cancers or Nonmalignant Features?
Yoko Satoh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Higher breast cancer conspicuity on dbPET compared to WB-PET/CT
Kayo Nishimatsu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors
Ryusuke Nakamoto et al.
NUCLEAR MEDICINE COMMUNICATIONS (2017)
A preliminary report of breast cancer screening by positron emission mammography
Yayoi Yamamoto et al.
ANNALS OF NUCLEAR MEDICINE (2016)
Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI
Doris Leithner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Performance evaluation of a high resolution dedicated breast PET scanner
Trinitat Garcia Hernandez et al.
MEDICAL PHYSICS (2016)
Comparative Analysis of Imaging Sensitivity of Positron Emission Mammography and Whole-Body PET in Relation to Tumor Size
Yayoi Yamamoto et al.
CLINICAL NUCLEAR MEDICINE (2015)
Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients
Sepideh Saadatmand et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients
Sepideh Saadatmand et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Clinical practice guideline for dedicated breast PET
Makoto Hosono et al.
ANNALS OF NUCLEAR MEDICINE (2014)
Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0
Hiroyoshi Fukukita et al.
ANNALS OF NUCLEAR MEDICINE (2014)
Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
Yoko Satoh et al.
BMC CANCER (2014)
Value of 18F-FDG PET/CT for Early Prediction of Pathologic Response (by Residual Cancer Burden Criteria) of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
Seok Mo Lee et al.
CLINICAL NUCLEAR MEDICINE (2014)
Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT
Judith E. Kalinyak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Performance Evaluation of a New Dedicated Breast PET Scanner Using NEMA NU4-2008 Standards
Kanae K. Miyake et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
A Molecular Approach to Breast Imaging
Amy M. Fowler
JOURNAL OF NUCLEAR MEDICINE (2014)
Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures
Nikolaos E. Makris et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Performance of FDG PET/CT in the Clinical Management of Breast Cancer
David Groheux et al.
RADIOLOGY (2013)
Initial clinical test of a breast-PET scanner
Raymond R. Raylman et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2011)
Initial Characterization of a Dedicated Breast PET/CT Scanner During Human Imaging
Spencer L. Bowen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer
Rakesh Kumar et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Comparison of rectangular and dual-planar positron emission mammography scanners
JY Qi et al.
IEEE TRANSACTIONS ON NUCLEAR SCIENCE (2002)
Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: Validation of the UICC T1 subgroup classification
N Ichizawa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2002)